# Phase 4C: Orthosis Design Validation & Comparison Report

## Executive Summary

**Top Recommendation: Design Rank 11**
- Composite Score: `0.792`
- Clinical Use: High support (therapeutic/intensive) | Minimal mobility (immobilization) | Ultra-lightweight (minimal print time) | FAILS one or more FEA checks [REVIEW]

Total Designs Analyzed: **16**

## Design Comparison Matrix

| Rank | Score | Support | Movement | Efficiency | Fabric | Voxels | Weight (g) | FEA | Recommendation |
|------|-------|---------|----------|------------|--------|--------|------------|-----|----------------|
| 11 | 0.792 | 89.4% | 43.9% | 95.5% | 100.0% | 18 | 0.17 | FAIL | High support (therapeutic/intensive) | M... |
| 1 | 0.782 | 84.8% | 50.0% | 92.5% | 100.0% | 30 | 0.29 | FAIL | Good support (standard therapy) | Modera... |
| 16 | 0.778 | 85.6% | 48.0% | 91.2% | 100.0% | 35 | 0.34 | FAIL | High support (therapeutic/intensive) | M... |
| 8 | 0.775 | 86.9% | 48.9% | 86.8% | 100.0% | 53 | 0.51 | FAIL | High support (therapeutic/intensive) | M... |
| 13 | 0.775 | 86.0% | 48.5% | 88.5% | 100.0% | 46 | 0.44 | FAIL | High support (therapeutic/intensive) | M... |
| 7 | 0.775 | 86.6% | 50.8% | 85.0% | 100.0% | 60 | 0.58 | FAIL | High support (therapeutic/intensive) | M... |
| 3 | 0.775 | 83.8% | 47.9% | 92.8% | 100.0% | 29 | 0.28 | FAIL | Good support (standard therapy) | Modera... |
| 15 | 0.773 | 86.3% | 48.9% | 86.5% | 100.0% | 54 | 0.52 | FAIL | High support (therapeutic/intensive) | M... |
| 5 | 0.771 | 87.0% | 51.1% | 82.2% | 100.0% | 71 | 0.68 | FAIL | High support (therapeutic/intensive) | M... |
| 14 | 0.770 | 85.2% | 49.1% | 87.0% | 100.0% | 52 | 0.50 | FAIL | High support (therapeutic/intensive) | M... |

## FEA Validation Results

| Rank | Max Stress (MPa) | Peak Strain | Max Deflection (mm) | Support Eff. | Pass |
|------|-----------------|-------------|---------------------|--------------|------|
| 11 | 36.00 | 0.0112 | 0.04 | 0.302 | FAIL |
| 1 | 36.00 | 0.0112 | 0.04 | 0.451 | FAIL |
| 16 | 36.00 | 0.0112 | 0.04 | 0.503 | FAIL |
| 8 | 36.00 | 0.0112 | 0.04 | 0.654 | FAIL |
| 13 | 36.00 | 0.0112 | 0.04 | 0.601 | FAIL |
| 7 | 36.00 | 0.0112 | 0.04 | 0.699 | FAIL |
| 3 | 36.00 | 0.0112 | 0.04 | 0.440 | FAIL |
| 15 | 36.00 | 0.0112 | 0.04 | 0.660 | FAIL |
| 5 | 36.00 | 0.0112 | 0.04 | 0.758 | FAIL |
| 14 | 36.00 | 0.0112 | 0.04 | 0.647 | FAIL |

## Clinical Recommendations

### For Maximum Support (Therapeutic)
- **Rank 11**: High support (therapeutic/intensive) | Minimal mobility (immobilization) | Ultra-lightweight (minimal print time) | FAILS one or more FEA checks [REVIEW]
- **Rank 16**: High support (therapeutic/intensive) | Moderate mobility (functional support) | Ultra-lightweight (minimal print time) | FAILS one or more FEA checks [REVIEW]
- **Rank 8**: High support (therapeutic/intensive) | Moderate mobility (functional support) | Lightweight (efficient fabrication) | FAILS one or more FEA checks [REVIEW]

### For Lightweight Daily Wear
- **Rank 1**: Good support (standard therapy) | Moderate mobility (functional support) | Ultra-lightweight (minimal print time) | FAILS one or more FEA checks [REVIEW]